Partially reversible bortezomib-induced cardiotoxicity: an unusual cause of acute cardiomyopathy

• Hauptverfasser: Marcelle G. Meseeha (Verfasst von), Victor O. Kolade (Verfasst von), Maximos N. Attia (Verfasst von)
• Format: Buch
• Veröffentlicht: Greater Baltimore Medical Center, 2015-12-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Chemotherapy-associated cardiotoxicity can present as a spectrum from arrhythmia to acute congestive heart failure. Unlike anthracyclines, proteasome inhibitors - for example, bortezomib - are not notorious for causing cardiotoxicity in absence of pre-existing cardiac dysfunction or without concomit...